Analysis of promoter function in Aspergillus fumigatus

Eukaryotic Cell

Volumn 11, Issue 9, 2012, Pages 1167-1177

  Paul, Sanjoy ^a   Stacey Klutts, J ^a,b   Scott Moye Rowleya, W ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VA Health Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P 450 CYP51A, ASPERGILLUS; CYTOCHROME P-450 CYP51A, ASPERGILLUS; CYTOCHROME P450; FUNGAL PROTEIN; HEAT SHOCK PROTEIN 70; LUCIFERASE; RECOMBINANT PROTEIN;

ARTICLE; ASPERGILLUS FUMIGATUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; PROMOTER REGION; REPORTER GENE;

ASPERGILLUS FUMIGATUS; CYTOCHROME P-450 ENZYME SYSTEM; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENES, REPORTER; HSP70 HEAT-SHOCK PROTEINS; LUCIFERASES; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC;

ASPERGILLUS FUMIGATUS; FUNGI;

EID: 84865535907     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00174-12     Document Type: Article

References (58)

1. Albarrag AM, et al. 2011. Interrogation of related clinical pan-azoleresistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob. Agents Chemother. 55:5113-5121.
2. Arendrup MC, et al. 2010. Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One 5:e10080. doi:10.1371/journal.pone.0010080.
3. Blosser SJ, Cramer RA. 2012. SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A). Antimicrob. Agents Chemother. 56:248-257.
4. Brock M. 2012. Application of bioluminescence imaging for in vivo monitoring of fungal infections. Int. J. Microbiol. 2012:956794. doi:10.1155/ 2012/956794.
5. Brock M, et al. 2008. Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl. Environ. Microbiol. 74:7023-7035.
6. Bueid A, et al. 2010. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J. Antimicrob. Chemother. 65:2116-2118.
7. Burgel PR, et al. 2012. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob. Agents Chemother. 56:869-874.
8. Casadaban MJ, Martinez-Arias A, Shapira SK, Chou J. 1983. Betagalactosidase gene fusions for analyzing gene expression in E. coli and yeast. Methods Enzymol. 100:293-308.
9. Chowdhary A, et al. 2012. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J. Antimicrob. Chemother. 67:362-366.
10. Craig E, Ziegelhoffer T, Nelson J, Laloraya S, Halladay J. 1995. Complex multigene family of functionally distinct Hsp70s of yeast. Cold Spring Harb. Symp. Quant Biol. 60:441-449.
11. D'Enfert C, Vecchiarelli A, Brown AJ. 2010. Bioluminescent fungi for real-time monitoring of fungal infections. Virulence 1:174-176.
12. Denning DW, et al. 2011. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 52:1123-1129.
13. Donat S, et al. 2012. Surface display of Gaussia princeps luciferase allows sensitive fungal pathogen detection during cutaneous aspergillosis. Virulence 3:51-61.
14. Fidel S, Doonan JH, Morris NR. 1988. Aspergillus nidulans contains a single actin gene which has unique intron locations and encodes a gammaactin. Gene 70:283-293.
15. Gibbons JG, et al. 2012. Global transcriptome changes underlying colony growth in the opportunistic human pathogen Aspergillus fumigatus. Eukaryot. Cell 11:68-78.
16. Guarente L. 1983. Yeast promoter and lacZ fusions designed to study expression of cloned genes in yeast. Methods Enzymol. 101:181-191.
17. Gulshan K, Moye-Rowley WS. 2007. Multidrug resistance in fungi. Eukaryot. Cell 6:1933-1942.
18. Hahn S, Young ET. 2011. Transcriptional regulation in Saccharomyces cerevisiae: transcription factor regulation and function, mechanisms of initiation, and roles of activators and coactivators. Genetics 189:705-736.
19. Howard SJ, et al. 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15:1068-1076.
20. Howard SJ, et al. 2006. Multi-azole resistance in Aspergillus fumigatus. Int. J. Antimicrob. Agents 28:450-453.
21. Hu W, et al. 2007. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog. 3:e24. doi:10.1371/ journal.ppat.0030024.
22. Jungwirth H, Kuchler K. 2006. Yeast ABC transporters-a tale of sex, stress, drugs and aging. FEBS Lett. 580:1131-1138.
23. Kafer E. 1977. Meiotic and mitotic recombination in Aspergillus and its chromosomal aberrations. Adv. Genet. 19:33-131.
24. Krappmann S, Sasse C, Braus GH. 2006. Gene targeting in Aspergillus fumigatus by homologous recombination is facilitated in a nonhomologous end-joining-deficient genetic background. Eukaryot. Cell 5:212-215.
25. Kubodera T, Yamashita N, Nishimura A. 2002. Transformation of Aspergillus sp. and Trichoderma reesei using the pyrithiamine resistance gene (ptrA) of Aspergillus oryzae. Biosci. Biotechnol. Biochem. 66:404-406.
26. Langfelder K, Philippe B, Jahn B, Latge JP, Brakhage AA. 2001. Differential expression of the Aspergillus fumigatus pksP gene detected in vitro and in vivo with green fluorescent protein. Infect. Immun. 69:6411-6418.
27. Liebmann B, Gattung S, Jahn B, Brakhage AA. 2003. cAMP signaling in Aspergillus fumigatus is involved in the regulation of the virulence gene pksP and in defense against killing by macrophages. Mol. Genet. Genomics 269:420-435.
28. Liebmann B, Muller M, Braun A, Brakhage AA. 2004. The cyclic AMPdependent protein kinase a network regulates development and virulence in Aspergillus fumigatus. Infect. Immun. 72:5193-5203.
29. Lionakis MS, et al. 2005. Increased frequency of non-fumigatus Aspergillus species in amphotericin B-or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn. Microbiol. Infect. Dis. 52:15-20.
30. Lockhart SR, et al. 2011. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/ L98H mutation in the cyp51A gene. Antimicrob. Agents Chemother. 55: 4465-4468.
31. Mavridou E, Bruggemann RJ, Melchers WJ, Mouton JW, Verweij PE. 2010. Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene. Antimicrob. Agents Chemother. 54:860-865.
32. McLean M, et al. 1995. Organization of the Saccharomyces cerevisiae actin gene UAS: functional significance of reiterated REB1 binding sites and AT-rich elements. Mol. Microbiol. 18:605-614.
33. Meletiadis J, Mavridou E, Melchers WJ, Mouton JW, Verweij PE. 2012. Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis. Antimicrob. Agents Chemother. 56:2524-2529.
34. Mellado E, et al. 2007. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob. Agents Chemother. 51:1897-1904.
35. Morio F, et al. 2012. High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis. J. Antimicrob. Chemother. 67:1870-1873.
36. Mortensen KL, et al. 2011. Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. J. Clin. Microbiol. 49:2243-2251.
37. Mortensen KL, et al. 2010. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob. Agents Chemother. 54:4545-4549.
38. Mullins ED, et al. 2001. Agrobacterium-mediated transformation of Fusarium oxysporum: an efficient tool for insertional mutagenesis and gene transfer. Phytopathology 91:173-180.
39. Nascimento AM, et al. 2003. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob. Agents Chemother. 47:1719-1726.
40. Nierman WC, et al. 2005. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438:1151-1156.
41. Orr-Weaver TL, Szostak JW, Rothstein RJ. 1981. Yeast transformation: a model system for the study of recombination. Proc. Natl. Acad. Sci. U. S. A. 78:6354-6358.
42. Osmani SA, May GS, Morris NR. 1987. Regulation of the mRNA levels of nimA, a gene required for the G2-M transition in Aspergillus nidulans. J. Cell Biol. 104:1495-1504.
43. Pain A, et al. 2004. Insight into the genome of Aspergillus fumigatus: analysis of a 922 kb region encompassing the nitrate assimilation gene cluster. Fungal Genet. Biol. 41:443-453.
44. Paul S, Schmidt JA, Moye-Rowley WS. 2011. Regulation of the CgPdr1 transcription factor from the pathogen Candida glabrata. Eukaryot. Cell 10:187-197.
45. Prasad R, Goffeau A. 2012. Yeast ATP-binding cassette transporters conferring multidrug resistance. Annu. Rev. Microbiol. [Epub ahead of print.] doi:10.1146/annurev-micro-092611-150111.
46. Punt PJ, et al. 1990. Functional elements in the promoter region of the Aspergillus nidulans gpdA gene encoding glyceraldehyde-3-phosphate dehydrogenase. Gene 93:101-109.
47. Rose MD, Misra LM, Vogel JP. 1989. KAR2, a karyogamy gene, is the yeast homolog of the mammalian BiP/GRP78 gene. Cell 57:1211-1221.
48. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
49. Sikorski RS, Hieter P. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
50. Smith JM, Tang CM, Van Noorden S, Holden DW. 1994. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect. Immun. 62:5247-5254.
51. Snelders E, Melchers WJ, Verweij PE. 2011. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis? Future Microbiol. 6:335-347.
52. Snelders E, et al. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 5:e219. doi:10.1371/journal.pmed.0050219.
53. Sonenberg N, Hinnebusch AG. 2009. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136:731-745.
54. Srikantha T, et al. 1996. The sea pansy Renilla reniformis luciferase serves as a sensitive bioluminescent reporter for differential gene expression in Candida albicans. J. Bacteriol. 178:121-129.
55. Srikantha T, Zhao R, Daniels K, Radke J, Soll DR. 2005. Phenotypic switching in Candida glabrata accompanied by changes in expression of genes with deduced functions in copper detoxification and stress. Eukaryot. Cell 4:1434-1445.
56. Sugareva V, et al. 2006. Characterisation of the laccase-encoding gene abr2 of the dihydroxynaphthalene-like melanin gene cluster of Aspergillus fumigatus. Arch. Microbiol. 186:345-355.
57. Sugui JA, Chang YC, Kwon-Chung KJ. 2005. Agrobacterium tumefaciens-mediated transformation of Aspergillus fumigatus: an efficient tool for insertional mutagenesis and targeted gene disruption. Appl. Environ. Microbiol. 71:1798-1802.
58. Zhang Z, Dietrich FS. 2005. Mapping of transcription start sites in Saccharomyces cerevisiae using 5= SAGE. Nucleic Acids Res. 33:2838-2851.